Medically reviewed by Jessica Swirble, PharmDLast updated on April 18, 2025
Drug Information| | |
Celecoxib is an effective and well-established COX-2 inhibitor for the treatment of various inflammatory conditions, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is primarily used to relieve pain and reduce inflammation related to conditions like rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. The drug works by blocking cyclooxygenase enzymes that produce prostaglandins that cause inflammation.
The drug is available in various forms, including a 50-umbing-tab, a 20-umbing-tab, and a 200-umbing-tab. The 20-umbing-tab is a liquid suspension that must be shaken before use. The other forms of Celecoxib are a 20umbing-tab, a 100umbing-tab, and a 200umbing-tab. The liquid suspension is commonly used for the treatment of mild-to-moderate pain and inflammation.
The drug's active ingredient is Celecoxib. Celecoxib is a brand-name NSAID and is also used to relieve pain and inflammation associated with conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Celecoxib is used to relieve symptoms of pain, such as headache, menstrual cramps, muscle strains, sore throat, and menstrual cramps that occur as a result of everyday activities, including:
The use of Celecoxib can lead to a drop in blood pressure, sedation, and even more trouble with driving.
Research has shown that the risk of cardiovascular events with dosage adjustments is slightly higher for individuals at higher risk of cardiovascular events.
However, the use of Celecoxib is not recommended in individuals with a history of cardiovascular events or those at increased risk of.
The use of Celecoxib is not recommended for use in patients with a history of cardiovascular events or a known cardiovascular disease. It is also not recommended for use in patients with a known history of cardiovascular events or those at increased risk of cardiovascular events.
The use of Celecoxib is not recommended in patients with a known history of cardiovascular events or a known cardiovascular disease.
The use of Celecoxib is not recommended for use in patients with a known history of cardiovascular events or a known cardiovascular disease. It is also not recommended for use in patients with a known history of cardiovascular events or those at increased risk of
of
pregnancy and breast cancer.
The use of Celecoxib is not recommended in individuals with a history of cardiovascular events or a known cardiovascular disease. It is also not recommended for use in individuals with a known history of cardiovascular events or a known cardiovascular disease.
The use of Celecoxib is not recommended in use in patients with a known history of cardiovascular events or a known cardiovascular disease. It is also not recommended for use in use in individuals with a known history of cardiovascular events or at increased risk of
.
The use of Celecoxib is not recommended for use in use in individuals with a known history of cardiovascular events or a known cardiovascular disease. It is also not recommended for use in use in individuals with a known history of cardiovascular events or at increased risk of.
It is also not recommended for use in use in use in use by individuals at increased risk of cardiovascular events.
Celecoxib, commonly known by the brand name Celebrex, is a nonsteroidal anti-inflammatory drug (NSAID) available at a significant price point. It is widely used for the relief of various symptoms associated with inflammation and pain including swelling, tenderness, and tenderness-related pain and discomfort. Here’s a comprehensive analysis of the market and price projections for Celecoxib.
The global Celecoxib market is poised for steady growth driven by several key factors:
Several key factors are driving the growth of the Celecoxib market:
North America is the dominant region in the Celecoxib market, driven by increasing awareness about chronic conditions and rising healthcare expenditure. The region is expected to see substantial growth due to the growing geriatric population and the increasing prevalence of cardiovascular diseases. The high prevalence of cardiovascular conditions and the aging population are key drivers[3].
The Asia Pacific region is expected to see significant growth due to increasing healthcare expenditure and increasing healthcare access. The region is expected to have a robust geriatric population, which in turn increases the Celecoxib market's demand[3].
Europe is the market leader in the Celecoxib market, driven by increasing awareness about chronic conditions and rising healthcare expenditure. The region is expected to experience substantial growth due to the increasing geriatric population and the growing trend towards healthier aging populations[3].
The rise of travel activities and the expanding geriatric population are key regions driving the Celecoxib market's growth. The increasing incidence of cardiovascular diseases and the growing geriatric population are key growth factors for the market, leading to a robust Celebrex market. The increased healthcare expenditure and the growing geriatric population are key drivers of the market.
North America is the dominant region in Celecoxib market, driven by increasing awareness about chronic conditions and rising healthcare expenditure. The region is expected to see substantial growth due to the growing geriatric population and the increasing prevalence of cardiovascular diseases[3].
CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
Direct medicinesCELEBREX 200MG CAPSULE is a prescription medicine. You will need to consult your doctor for direct medicines if you are pregnant, might become pregnant, or should take any medication for pain and inflammation.
Osteoarthritis and Rheumatoid Arthritis are chronic inflammatory disorders where joint tissue damages are triggered in the early stages of onset with chronic use of anti-inflammatory drugs. Direct medicines for direct medicines for osteoarthritis and rheumatoid arthritis medicines are listed below.
In addition, in ashaped area in the body called lumbar puncta,steve medicine contains talc.
CELEBREX 200MG CAPSULE contains febuxostat, febupfenital, and dibutyltetrazolylam trihydrate.
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Celebrex, a non-steroidal anti-inflammatory drug (NSAID) sold by Pfizer Inc. in the United States. This product is not FDA-approved for sale or consumption, and was found to be unsafe by the FDA. This product is sold by AstraZeneca as Celebrex, and is sold by Pfizer under the brand nameCelecoxib. Consult your physician before taking this or any other medicine.
According to the manufacturer's website, Celebrex is not approved for use in the treatment of arthritis, and is not intended to be a substitute for careful consideration of medical history and potential drug interactions. This package of products includes Celebrex and other non-steroidal anti-inflammatory drugs (NSAIDs), and was distributed to people with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and valvular heart disease. The products are sold by several companies in the United States and are distributed by Pfizer. For more information, see the "Contact Pfizer Products" link at the top of this page.
Included as a coincided version of this article may not be as complete as the version provided by the manufacturer.
--
Celebrex is a nonsteroidal anti-inflammatory drug (NSAID) that is used to reduce pain and inflammation and to treat osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and valvular heart disease. Celebrex is sold by AstraZeneca under the brand name Celecoxib. AstraZeneca develops and markets pharmaceuticals and diagnostered products in the United States and other countries. The Company develops and markets a wide range of pharmaceuticals, diagnostered products, and generic pharmaceuticals. The Company develops and markets a number of generic pharmaceuticals and a number of brand-name pharmaceuticals. The Company develops a wide range of generic pharmaceuticals. AstraZeneca markets a number of brand-name pharmaceuticals. Pfizer develops and markets a number of generic pharmaceuticals and a number of brand-name pharmaceuticals.Celebrex was developed by Pfizer and is manufactured by AstraZeneca. AstraZeneca is the controlling parent company of Pfizer. The Company develops and markets a number of pharmaceuticals, and a number of brand-name pharmaceuticals. Pfizer develops and markets a number of generic pharmaceuticals. Pfizer develops and markets a number of brand-name pharmaceuticals. AstraZeneca develops and markets a number of generic pharmaceuticals.
Stade de France Pharmacy